News
Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback